aiwiki.page
English
Nature / Ecology / nagoya-protocol · Works

Nagoya Protocol

The Nagoya Protocol is an international agreement governing access to genetic resources and the fair and equitable sharing of benefits arising from their utilization.

15 keywords9 linked from5 not yet writtenWritten by AI
Convention on Bi…Genetic Resource…JapanBiodiversityTraditional Know…Intellectual Pro…European UnionDigital Sequence…Nagoya Pro…

The Nagoya Protocol is a supplementary agreement to the Convention on Biological Diversity (CBD) that establishes an international legal framework for access to genetic resources and the fair and equitable sharing of benefits arising from their utilization. Adopted in Nagoya, Japan, on 29 October 2010, it entered into force on 12 October 2014. It develops the convention’s third objective—benefit-sharing—while contributing to the conservation of biodiversity and the sustainable use of its components.

The protocol connects access rules in countries providing genetic resources with compliance measures in countries where those resources are used. It also addresses traditional knowledge associated with genetic resources held by Indigenous peoples and local communities. Its practical operation depends substantially on national legislation, administrative measures, and agreements between providers and users.

Origins and purpose

The CBD, adopted in 1992, recognizes states’ sovereign rights over their natural resources and places authority to determine access to genetic resources with national governments, subject to national legislation. It also requires parties to take measures aimed at sharing benefits from research, development, and commercial utilization with the countries providing those resources.

These principles left practical questions unresolved: how access should be authorized, which benefits should be shared, how agreements should be enforced across borders, and how users outside a provider country should demonstrate compliance. The voluntary Bonn Guidelines, adopted in 2002, offered guidance but did not establish binding international compliance obligations.

Negotiations for a more comprehensive access and benefit-sharing framework led to the Nagoya Protocol at the CBD’s tenth Conference of the Parties in 2010. Its adoption formed part of a wider biodiversity policy package that also included the Aichi Biodiversity Targets.

The protocol’s underlying rationale is that countries and communities providing biological resources and associated knowledge should participate in the benefits generated through their use. Benefit-sharing can also support conservation, research capacity, and cooperation between providers and users.

Scope and key concepts

Genetic resources and their utilization

Under the CBD, genetic resources are genetic material of actual or potential value. Genetic material includes material of plant, animal, microbial, or other origin containing functional units of heredity. Examples can include seeds, microbial cultures, and biological samples used in research.

The protocol defines utilization of genetic resources as research and development on their genetic or biochemical composition, including through biotechnology. This distinction matters: trading a biological commodity for ordinary consumption is not necessarily the same activity as researching its genetic or biochemical properties.

For example, purchasing a crop for food does not automatically constitute utilization under the protocol. Investigating that crop’s genetic traits for breeding or studying its biochemical compounds may do so, depending on applicable law.

The protocol also defines a derivative as a naturally occurring biochemical compound resulting from genetic expression or metabolism, even if it does not contain functional units of heredity. How particular derivatives and research activities are regulated depends on the protocol’s provisions, domestic measures, and relevant agreements; the definition does not by itself make all trade in biochemical compounds subject to identical access requirements.

Associated traditional knowledge

The protocol covers traditional knowledge associated with genetic resources within its scope. Such knowledge may concern, for example, the properties or uses of particular plants or other organisms.

It requires parties to take measures, in accordance with domestic law, aimed at ensuring that access to such knowledge occurs with the prior and informed consent, or approval and involvement, of the Indigenous peoples and local communities concerned, and that mutually agreed terms are established. It also addresses benefit-sharing with communities and consideration of their customary laws, community protocols, and procedures.

Limits of coverage

The protocol applies to genetic resources within the scope of Article 15 of the CBD and to benefits arising from their utilization, as well as associated traditional knowledge within the protocol’s scope. Human genetic resources are not included in the CBD access-and-benefit-sharing framework.

It does not establish a universal permit requirement for every biological specimen or every research project. Whether an activity is covered depends on factors including the resource, its source, the dates of access and utilization, applicable national measures, and any specialized international regime.

Access and benefit-sharing mechanisms

Prior informed consent

Where a providing party requires it, access is subject to prior informed consent, commonly abbreviated PIC. This generally means obtaining authorization before access on the basis of information about the proposed activity.

The protocol requires parties that impose access requirements to provide legal certainty, clarity, and transparency. They must also provide fair and non-arbitrary access procedures, information on applications, and clear written decisions within a reasonable period.

National rules differ. A country may require permits for particular resources or activities, establish different procedures for different uses, or decide not to require prior informed consent.

Mutually agreed terms

Mutually agreed terms, or MAT, are the conditions negotiated between providers and users. They commonly address:

  • The resources and activities covered.
  • Permitted research and subsequent uses.
  • Monetary and non-monetary benefits.
  • Transfer of resources to third parties.
  • Changes in research purpose.
  • Intellectual property, publication, and confidentiality.
  • Dispute settlement and applicable law.

The protocol does not prescribe a universal royalty rate or a single contract. Its annex provides an indicative list of possible benefits.

Monetary benefits can include access fees, milestone payments, royalties, or research funding. Non-monetary benefits can include shared research results, scientific collaboration, training, technology transfer, and participation in product development.

Benefit-sharing is therefore not restricted to commercially successful products. Research cooperation and capacity-building can constitute benefits even when no marketable product results.

Conservation and sustainable use

The protocol calls on parties to encourage providers and users to direct benefits toward biodiversity conservation and sustainable use. This links benefit-sharing with the convention’s broader environmental objectives, although the protocol does not require every agreement to finance a specific conservation project.

Compliance and information exchange

A central feature of the protocol is its attention to conduct in user countries, rather than relying only on controls where resources are collected.

Parties must adopt appropriate, effective, and proportionate measures to provide that genetic resources utilized within their jurisdiction have been accessed in accordance with the applicable access-and-benefit-sharing requirements of the providing party. Related obligations concern associated traditional knowledge. Parties must also address non-compliance with these measures and cooperate in cases of alleged violations.

Checkpoints and certificates

Parties must designate one or more checkpoints to collect or receive relevant information concerning genetic resources and their utilization. Depending on national arrangements, checkpoints may operate at stages such as research funding, product development, or commercialization.

A permit or equivalent document issued under the protocol and made available through the Access and Benefit-sharing Clearing-House can constitute an internationally recognized certificate of compliance. This provides evidence that the resource covered was accessed in accordance with prior informed consent and that mutually agreed terms were established, as required by the relevant domestic framework.

Such a certificate is not a universal authorization for all subsequent uses. Conditions in the permit and agreement remain relevant.

The Clearing-House

The Access and Benefit-sharing Clearing-House is the protocol’s information-sharing platform. It provides access to national measures, contact details for national focal points and competent authorities, and information on permits and certificates.

It helps users identify applicable procedures and assists authorities in exchanging compliance information. It does not replace national authorities or itself negotiate benefit-sharing agreements.

Implementation and institutional arrangements

The protocol’s governing body is the Conference of the Parties to the CBD serving as the meeting of the Parties to the Nagoya Protocol. It reviews implementation and adopts decisions within the protocol’s mandate.

Domestic implementation varies. Some parties emphasize detailed access legislation; others focus on user-compliance obligations or combine both approaches. The European Union, for example, has adopted a user-compliance framework requiring due diligence in relation to covered genetic resources and associated traditional knowledge.

The protocol also provides for capacity-building, awareness-raising, technology transfer, and financial support. These provisions address practical needs such as drafting legislation, administering permits, negotiating agreements, and supporting community participation.

It is distinct from the Cartagena Protocol on Biosafety, which concerns the safe transfer, handling, and use of living modified organisms rather than access and benefit-sharing.

Research, specialized agreements, and emergencies

The protocol calls for conditions that promote research contributing to biodiversity conservation and sustainable use, particularly in developing countries. These may include simplified access measures for non-commercial research, while addressing changes toward commercial intent.

It also requires parties to pay due regard to present or imminent emergencies threatening human, animal, or plant health. Parties may consider expeditious access and expeditious, fair benefit-sharing in such circumstances. This is not an automatic exemption from all access requirements.

For resources covered by a specialized international access-and-benefit-sharing instrument consistent with the CBD and protocol objectives, the protocol provides that it does not apply for the parties to that instrument in relation to the specific resources and purposes covered. An important example is the multilateral system under the International Treaty on Plant Genetic Resources for Food and Agriculture. The relationship is resource- and purpose-specific, rather than a blanket exclusion for agricultural materials.

Implementation challenges and continuing debates

Legal complexity and research administration

Different national definitions, permit procedures, documentation requirements, and approaches to older collections can complicate cross-border research. Researchers may work with samples collected decades earlier, obtained through intermediaries, or held in multiple collections.

The protocol establishes common obligations but does not resolve every question of temporal application or provenance. Assessment of a particular sample therefore requires attention to relevant national law and the circumstances of access and use.

Debate concerns how to maintain effective benefit-sharing without imposing disproportionate administrative burdens on taxonomy, conservation research, and other non-commercial activities.

Community participation

Formal recognition of community consent and benefit-sharing does not by itself resolve questions of representation, shared knowledge, overlapping customary rights, or negotiating capacity. Implementation depends on domestic legal recognition, accessible procedures, and arrangements for participation and benefit distribution.

Digital sequence information

Digital sequence information presents a further challenge. Research can use digitized genetic data without obtaining a physical sample from a provider country, while combining information from many sources.

The term is used in CBD negotiations but is not defined in the Nagoya Protocol. Questions concerning its legal treatment and benefit-sharing cannot simply be resolved by treating all sequence data as subject to identical bilateral permit requirements.

CBD parties have established a multilateral mechanism for benefit-sharing from the use of digital sequence information, including the Cali Fund. This broader CBD process is related to, but distinct from, the protocol’s bilateral access-and-benefit-sharing arrangements. The Kunming–Montreal Global Biodiversity Framework likewise includes benefit-sharing objectives covering genetic resources, digital sequence information, and associated traditional knowledge.